Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study tracks 1,000 heart attack survivors to unlock recovery secrets

NCT ID NCT03539133

First seen Jan 24, 2026 · Last updated Jun 22, 2026 · Updated 26 times

Summary

This study is following 1,000 people who have had a severe type of heart attack called STEMI. Researchers are collecting detailed medical data to understand how different organs talk to each other during recovery. The goal is to find key signals that could lead to better treatments in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Division of Cardiology, Pulmonary Disease and Vascular Medicine

    RECRUITING

    Düsseldorf, 40225, Germany

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal new targets for treatments that improve heart function after a heart attack.

What could go wrong

This is an observational study, not a treatment trial. It collects data but does not test any therapy, so it cannot directly lead to a cure or new drug.

Conditions

The condition(s) this trial relates to.

anemia coronary artery disorder diabetes mellitus Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.